Related and Nonrelated Parties [Axis]
Nonrelated Party [Member]
Related Party [Member]
Product and Service [Axis]
Printed Products [Member]
Rental [Member]
Commercial Lending [Member]
Commission [Member]
Biotechnology [Member]
Equity Components [Axis]
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Customer [Axis]
Customer One [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Accounts Receivable [Member]
Customer Two [Member]
Customer Three [Member]
Customer Four [Member]
Customer Five [Member]
Legal Entity [Axis]
Impact BioMedical, Inc. [Member]
Short-Term Debt, Type [Axis]
Note 1 [Member]
Statistical Measurement [Axis]
Maximum [Member]
Note 2 [Member]
Note 3 [Member]
Note 4 [Member]
Investment, Name [Axis]
BMI Capital International LLC [Member]
Note 5 [Member]
Note 6 [Member]
Note 7 [Member]
Note 8 [Member]
Note 9 [Member]
Note Ten [Member]
Note 11 [Member]
Financial Instrument [Axis]
Convertible Bond Investment [Member]
True Partners Capital Holding Limited [Member]
Cash and Cash Equivalents [Axis]
Cash [Member]
Restricted Cash [Member]
Money Market Funds [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Marketable Securities [Member]
Class of Financing Receivable [Axis]
Loan [Member]
Financing Receivable Portfolio Segment [Axis]
General Loan Portfolio Reserve [Member]
Business Combination [Axis]
American Pacific Bancorp [Member]
Specific Loan Reserves [Member]
Asili LLC [Member]
VEII Inc [Member]
BMI Capital Inc [Member]
WUURII Commerce Inc [Member]
Individual Counterparty [Member]
Alset International Limited [Member]
Debt Instrument [Axis]
WestPark Capital Group, LLC. [Member]
West Park Capital, Inc [Member]
DSS Securities, Inc. [Member]
Premier Packaging Bank of America N.A. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Loan Agreement [Member]
AMRE Shelton LLC [Member]
Long-Lived Asset, Class [Axis]
Tenant Improvements [Member]
Facility [Member]
Land [Member]
BMIC Loan [Member]
Wilson Loan [Member]
Pinnacle Bank [Member]
LifeCare Agreement [Member]
Site Improvements [Member]
Minimum [Member]
AMRE Life Care Portfolio LLC [Member]
Security Agreement [Member]
Union Bank & Trust Company [Member]
Alset, Inc. [Member]
Securities Purchase Agreement [Member]
Convertible Promissory Note [Member]
Securities Purchase Agreement Convertible Promissory Note [Member]
Convertible Note Payable Related Party [Member]
License Agreement [Member]
Bio Medical [Member]
Employment Agreements [Member]
Title and Position [Axis]
Mr.Heuszels [Member]
Award Type [Axis]
First Year [Member]
Second Year [Member]
Third Year [Member]
Plan Name [Axis]
Equity Incentive Plan [Member]
Impact Bio Medical Inc [Member]
Aegis Capital Corp. [Member]
Location, Statement of Income, Balance [Axis]
Consolidation Items [Axis]
Operating Segments [Member]
Segments [Axis]
Product Packaging [Member]
Commercial Banking [Member]
Securities [Member]
Corporate Segment [Member]
Packaging Printing and Fabrication [Member]
Printed Products Revenue Information [Member]
Commercial and Security Printing [Member]
Real Property Rental Income [Member]
Commercial Lending Revenue Information [Member]
Net Investment Income [Member]
Retail Internet Sales [Member]
Biotechnology Revenue Information [Member]
Rental Income [Member]
Securities Revenue Information [Member]
Commission Income [Member]
Alset Note [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Entity Listing, Par Value Per Share
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventory
Investments in trading securities
Current portion of notes receivable
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Investment in real estate, net
Investment, cost method
Investment, equity method
Investment in equity securities
Other assets
Right-of-use assets
Goodwill
Other intangible assets, net
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and deferred revenue
Other current liabilities
Accrued interest on long-term debt
Current portion of lease liability
Current portion of long-term debt
Convertible note payable - related party, net
Total current liabilities
Long-term debt, net
Long term lease liability
Total liabilities
Commitments and contingencies (Note 13)
Stockholders’ equity (deficit)
Preferred stock, $.02 par value; 47,000 shares authorized, zero shares issued and outstanding on June 30, 2026 (zero on December 31, 2025)
Common stock, $.02 par value; 200,000,000 shares authorized, 10,042,518 shares issued and outstanding on June 30, 2026 (9,092,518 on December 31, 2025)
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity of the Company
Non-controlling interest in subsidiaries
Total stockholders’ equity
Total liabilities and stockholders’ equity
Statement of Financial Position [Abstract]
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Statement [Table]
Statement [Line Items]
Revenue:
Total revenue
Costs and expenses:
Cost of revenue
Selling, general and administrative (including stock-based compensation)
Total costs and expenses
Operating loss
Other income (expense):
Interest income
Interest income on note receivable, related party
Dividend income
Other income (expense)
Interest expense
Loss on equity method investment
(Loss) gain on investments
Impairment of intangible assets
Loss on sale of real estate
Loss from continuing operations before income taxes
Income tax benefit
Net loss
Loss from operations attributed to noncontrolling interest
Net loss attributable to DSS common stockholders
Loss per common share attributable to common stock holders
Basic
Diluted
Shares used in computing loss per common share:
Basic
Diluted
Balance
Balance, shares
Stock-based payments for professional services
Stock-based payments - Impact BioMedical, Inc.
Issuance of common stock, net of expenses - Impact BioMedical, Inc.
Issuance of common stock for bonus
Balance, shares
Net loss
Issuance of common stock, net of expenses
Balance, shares
Fair value adjustment related to convertible bond received from related party
Issuance of warrants in connection with convertible promissory note
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization
Issuance of common stock for bonus
Stock-based payments for professional services rendered
Stock-based payments to employees and directors
Loss on equity method investment
Unrealized loss on investments
Change in ROU assets
(Loss) gain on allowance for obsolescence of inventory
Provision for loan loss recoveries
Impairment of intangible asset
Amortization of debt discount
Loss on sale of real estate
Decrease (increase) in assets:
Accounts receivable
Inventory
Assets held for sale
Prepaid expenses and other current assets
Investments in trading securities
Other assets
Increase (decrease) in liabilities:
Accounts payable
Accrued expenses
ROU liabilities
Accrued interest on notes payable
Other liabilities
Net cash (used) provided by operating activities
Cash flows from investing activities:
Purchase of property, plant and equipment
Purchase of convertible bond - related party
Sale of real estate
Sale of investment, related party
Issuance of new notes receivable, net origination fees
Payments received on notes receivable
Net cash (used) provided by investing activities
Cash flows from financing activities:
Payments of long-term debt
Borrowings of long-term debt, net
Payment on margin loans
Borrowings of convertible note payable - related party
Issuances of common stock, net of issuance costs
Net cash provided (used) by financing activities
Net decrease in cash
Cash, cash equivalents and restricted cash at beginning of period
Cash and cash equivalents at end of period
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies
Revenue from Contract with Customer [Abstract]
Revenue
Inventory Disclosure [Abstract]
Inventory
Receivables [Abstract]
Notes Receivable
Schedule of Investments [Abstract]
Convertible Bond Investment – related party
Investments, All Other Investments [Abstract]
Financial Instruments
Credit Loss [Abstract]
Provision for Credit Losses
Discontinued Operations and Disposal Groups [Abstract]
Disposal of assets
Investments
Debt Disclosure [Abstract]
Short-Term and Long-Term Debt
Lease Liability
Lease Liability
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Equity [Abstract]
Stockholders’ Equity
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information
Segment Reporting [Abstract]
Segment Information
Related Party Transactions [Abstract]
Related Party Transactions
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation
Principles of Consolidation
Use of Estimates
Reclassifications
Cash Equivalents
Accounts Receivable
Concentration of Credit Risk
Notes receivable, unearned interest, and related recognition
Allowance For Loans Losses
Investments
Fair Value of Financial Instruments
Inventory
Investments in real estate, net
Convertible bond investment
Intangible Assets
Goodwill
Impairment of Long-Lived Assets and Goodwill
Convertible Promissory Note
Business Combinations and Acquisitions
Loss Per Common Share
Share-Based Payments
Income Taxes
Going Concern
Related Party Transactions
Recently Issued Accounting Pronouncements
Schedule of Inventory
Schedule of Cash and Marketable Securities by Significant Investment Category
Schedule of Long-Term And Current Debt
Schedule of Future Minimum Lease Payments
Schedule of Supplemental Cash Flow Information
Schedule of Operations by Reportable Segment
Schedule of Disaggregation of Revenue
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Other operating expenses
Accounts receivable, net
Reserve for credit losses
Concentration of credit risk percentage
Allowance for loans losses
Inventory, allowance for obsolescence
Potential dilutive instruments issued and outstanding
Cash
Working capital
Sale of marketable securities
Sales commissions
Finished Goods
Work in Process
Raw Materials
Inventory gross
Less allowance for obsolescence
Inventory net
Financing Receivable, Modified [Table]
Financing Receivable, Modified [Line Items]
Note principal amount
Note interest rate
Note maturity date
Debt conversion description
Note principal and interest outstanding
Reserve amount against principal and interest outstanding
Maturity date description
Ownership percentage
Current notes receivable
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Bond face value
Interest rate
Maturity date
Conversion price per share
Convertible shares
Estimated fair value of convertible bond
Fair value of debt-like component
Fair value of equity-like conversion feature
Additional paid-in capital
Convertible bond recognized loss
Shares issued for conversion of bonds
Accrued interest
Increase in fair value of convertible bond
Debt instrument convertible threshold percentage of stock price trigger
Cash and Cash Equivalent [Table]
Cash and Cash Equivalents [Line Items]
Cost
Unrealized Gain/(Loss)
Fair Value
Cash and Cash Equivalents
Current marketable securities
Financing Receivable, Past Due [Table]
Financing Receivable, Past Due [Line Items]
Loan loss reserve
Portfolio reserve
Outstanding principal and interest
Sale of retail space
Assets held for sales
Gain on the sale of assets
InvestmentsTable [Table]
InvestmentsLineItems [Line Items]
Ownership shares
Percentage of outstanding shares
Fair value of marketable securities
Unrealized loss on investments
Shares new issues
Issuance of common stock for bonus, shares
Number of shares acquired
Investments
Estimated fair value of debt
Convertible bond investment fair value
Gain from change in fair value of convertible bond
Marketable securities unrealized gain loss
Number of shares issued
Outstanding membership interest
Equity method investment
2026
2027
2028
2029
2030
Thereafter
Total
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Debt financing amount
Principal amount
Simple interest rate
Long term debt current
Long term debt
Interest expense
Debt instrument description
Interest rate
Debt instrument balloon payment
Area of land
Payments to acquire assets
Payments to intangible assets
Estimated useful life
Net book value of assets
Deferred finance costs net
Non-current liabilities held for sale assets
Maturity date
Purchase price
Real estate assets held for development and sale
Accrued interest
Principal and interest payable
Convertible promissory note
Debt conversion price per share
Convertible bond investment fair value
Converted outstanding price
Purchase of warrant
Exercise price
Allocated description
Proceeds from issuance of convertible promissory note
Schedule Of Future Minimum Lease Payments
2026
2027
2028
2029
2030
After
Total lease payments
Less imputed interest
Present value of remaining lease payments
Current
Non-current
Weighted-average remaining lease term (years)
Weighted average discount rate
Leases [Abstract]
Operating lease, cash paid
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Loss contingency allegations
Sale of royalty percentage
Development cost, percent
Development costs
Commitments and Contingencies
Employment term bonus
Accrued bonus
EquityTable [Table]
Common stock under the plan for services
Common stock under the plan for services, value
Number of shares sold
Value of shares sold
Non controlling interest
Number of shares sold, per shares
Net of expenses
Shares issued for payment of legal fees
Legal fees received
Stock issued due to business acquisitions, value
Stock issued due to business acquisitions, shares
Stock issued for debt conversion
Number of grants shares issued
Purchase price per share
Proceeds from grants
Fair value grants
Stock based compensation expense
Non controlling interest
Cash paid for interest
Non-cash investing and financing activities:
Fair value adjustment related to convertible bond received from related party
Conversion of convertible bond investment – related party into equity method investment
Transfer of investment in equity securities to equity method investment upon obtaining significant influence
Issuance of warrants in connection with convertible promissory note from related party
Segment Reporting [Table]
Segment Reporting [Line Items]
Revenue
Cost of revenue
Gross profit (loss)
Operating expense
Operating income (loss)
Net income (loss) from operations before taxes
Number of reportable segments
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Investment owned
Fair value of marketable securities
Unrealized gain loss on investments
Equity method investment ownership percentage
Face amount
Debt instrument maturity date
Notes and loans receivable gross current
Price per share
Fair value of note
Assets held for sales.
Alset International Limited [Member]
Investment in real estate, net.
Investments cost method.
Accrued expenses and deferred revenue current.
True Partners Capital Holding Limited [Member]
Convertible Bond Investment [Member]
Estimated fair value of debt.
WestPark Capital Group, LLC. [Member]
West Park Capital, Inc [Member]
DSS Securities, Inc. [Member]
Outstanding membership interest.
BMI Capital International LLC [Member]
Equity method investment.
Convertible bond investment.
Amount of gain or loss recognized in earnings resulting from the subsequent measurement of a convertible bond investment acquired from or held with a related party, where the entity has elected the fair value option.
Debt financing amount.
Premier Packaging Bank of America N.A. [Member]
Net Investment Income [Member]
Interest income on notes receivable, related party
Loan Agreement [Member]
AMRE Shelton LLC [Member]
Tenant Improvements [Member]
Facility [Member]
BMIC Loan [Member]
Wilson Loan [Member]
Issuance of common stock net of expenses to subsidiary.
Pinnacle Bank [Member]
LifeCare Agreement [Member]
Site Improvements [Member]
AMRE Life Care Portfolio LLC [Member]
Security Agreement [Member]
Union Bank & Trust Company [Member]
Alset, Inc. [Member]
Equity Incentive Plan [Member]
Securities Purchase Agreement [Member]
Allocated description
Customer One [Member]
Convertible Promissory Note [Member]
Customer Two [Member]
Customer Three [Member]
Customer Four [Member]
Customer Five [Member]
Notes Receivable Unearned Interest and Related Recognition [Policy Text Block]
Allowance For Loans and Lease Losses [Policy Text Block]
Convertible Note Payable Related Party [Member]
Long term debt maturities repayments of principal in year after year four.
Impact BioMedical, Inc. [Member]
Convertible Promissory Note [Policy Text Block]
Lessee operating lease liability payments due after year four.
Going Concern [Policy Text Block]
Related Party Transactions [Policy Text Block]
Securities Purchase Agreement Convertible Promissory Note [Member]
Sales commissions capitalized.
License Agreement [Member]
Bio Medical [Member]
Sale of royalty percentage.
Development cost percent.
Note 1 [Member]
Employment Agreements [Member]
Mr.Heuszels [Member]
Second Year [Member]
Third Year [Member]
First Year [Member]
Note 2 [Member]
Note 3 [Member]
Shares issued in lieu of cash as payment for legal services.
Note 4 [Member]
Net value or share count of common or ordinary stock issued to employees or directors as compensation or bonuses in lieu of traditional cash payments during the period.
BMI Capital Inc [Member]
Note 5 [Member]
Impact Bio Medical Inc [Member]
Aegis Capital Corp. [Member]
Note 6 [Member]
Note 7 [Member]
Note 8 [Member]
Note 9 [Member]
Note Ten [Member]
Fair value grants
Product Packaging [Member]
Commercial Banking [Member]
Biotechnology [Member]
Securities [Member]
Packaging Printing and Fabrication [Member]
Printed Products Revenue Information [Member]
Commercial and Security Printing [Member]
Real Property Rental Income [Member]
Restricted Cash [Member]
Marketable Securities [Member]
Commercial Lending Revenue Information [Member]
Retail Internet Sales [Member]
Biotechnology Revenue Information [Member]
Loan [Member]
Business combination consideration transferred loan loss reverves.
General Loan Portfolio Reserve [Member]
American Pacific Bancorp [Member]
Specific Loan Reserves [Member]
Asili LLC [Member]
VEII Inc [Member]
Rental Income [Member]
Securities Revenue Information [Member]
Commission Income [Member]
WUURII Commerce Inc [Member]
Alset Note [Member]
Convertible Bond Investment [Policy Text Block]
Printed Products [Member]
Biotechnology Retail Sales [Member]
Commission Revenue [Member]
Note 11 [Member]
Rental [Member]
Commercial Lending [Member]
Commission [Member]
Stock based payments for professional services rendered.
Change in inventory obsolescence.
Provision for loan losses.
Increase decrease assets held for sale.
Purchase of convertible bond - related party.
Proceed from sale of real estate.
Proceeds from sale of investment related party.
Issuance of new notes receivable, net origination fees.
Issuance of common stock for bonus.
Change in fair value of convertible note payable related party.
(Loss) gain on allowance for obsolescence of inventory.
Negative working capital.
Fair value adjustment related to convertible bond received from related party.
Conversion of convertible bond investment – related party into equity method investment.
Issuance of warrants in connection with convertible promissory note from related party.
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Equity, Including Portion Attributable to Noncontrolling Interest
Liabilities and Equity
Income Tax Expense (Benefit)
Net Income (Loss) Attributable to Noncontrolling Interest
Net Income (Loss) Attributable to Parent
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Diluted
Shares, Outstanding
IssuanceOfCommonStockForBonus
Equity Method Investment, Realized Gain (Loss) on Disposal
Gain (Loss) on Disposition of Assets
GainLossOnAllowanceForObsolescenceOfInventory
Impairment of Real Estate
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories
IncreaseDecreaseAssetsHeldForSale
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI
Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Accounts Payable
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Other Property, Plant, and Equipment
PurchaseOfConvertibleBondRelatedParty
IssuanceOfNewNotesReceivableNetOriginationFees
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Repayments of Long-Term Debt
Payments of Loan Costs
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect, Continuing Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Inventory Disclosure [Text Block]
Lessee, Operating Leases [Text Block]
Investment, Policy [Policy Text Block]
Inventory, Policy [Policy Text Block]
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Related Party Transactions [Policy Text Block]
Accounts Receivable, after Allowance for Credit Loss
Inventory, Gross
Investments [Default Label]
Debt Instrument, Interest Rate, Effective Percentage
Interest Receivable
Convertible Debt, Fair Value Disclosures
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Lessee, Operating Lease, Liability, to be Paid, Year One
Lessee, Operating Lease, Liability, to be Paid, Year Two
Lessee, Operating Lease, Liability, to be Paid, Year Three
Lessee, Operating Lease, Liability, to be Paid, Year Four
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
FairValueAdjustmentRelatedToConvertibleBondReceivedFromRelatedParty
Cost of Revenue